Lexicon Pharmaceuticals reported 14K in Gross Profit on Sales for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US $ 6908M 160M
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Acorda Therapeutics ACOR:US $ 16.57M 16.2M
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
AstraZeneca AZN:LN 8.94B 2.9B
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Clovis Oncology CLVS:US $ 24.83M 1.4M
Coherus Biosciences CHRS:US $ 50.74M 10.52M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Halozyme Therapeutics HALO:US $ 101.36M 20.94M
Illumina ILMN:US $ 815M 2M
Insmed INSM:US $ 40.92M 1.92M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
Johnson & Johnson JNJ:US $ 15828M 1021M
MacroGenics MGNX:US 11.05M 2.15M
Mannkind MNKD:US $ 0.99M 0.09M
Merk MRK:US $ 10567M 873M
Moderna Inc MRNA:US 5.05B 1.21B
Novartis NOVN:VX 9.52B 3M
Puma Biotechnology PBYI:US $ 34.89M 8.57M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Thermo Fisher Scientific TMO:US $ 5464M 210M
Ultragenyx Pharmaceutical RARE:US $ 73.83M 6.04M
United Therapeutics UTHR:US $ 436M 55.4M